用户名: 密码: 验证码:
A Tale of Two Subunits: How the Neomorphic R132H IDH1 Mutation Enhances Production of 伪HG
详细信息    查看全文
文摘
Heterozygously expressed single-point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2, respectively) render these dimeric enzymes capable of producing the novel metabolite 伪-hydroxyglutarate (伪HG). Accumulation of 伪HG is used as a biomarker for a number of cancer types, helping to identify tumors with similar IDH mutations. With IDH1, it has been shown that one role of the mutation is to increase the rate of conversion from 伪KG to 伪HG. To improve our understanding of the function of this mutation, we have detailed the kinetics of the normal (isocitrate to 伪KG) and neomorphic (伪KG to 伪HG) reactions, as well as the coupled conversion of isocitrate to 伪HG. We find that the mutant IDH1 is very efficient in this coupled reaction, with the ability to form 伪HG from isocitrate and NADP+. The wild type/wild type IDH1 is also able to catalyze this conversion, though it is much more sensitive to concentrations of isocitrate. This difference in behavior can be attributed to the competitive binding between isocitrate and 伪KG, which is made more favorable for 伪KG by the neomorphic mutation at arginine 132. Thus, each partial reaction in the heterodimer is functionally isolated from the other. To test whether there is a cooperative effect resulting from the two subunits being in a dimer, we selectively inactivated each subunit with a secondary mutation in the NADP/H binding site. We observed that the remaining, active subunit was unaffected in its associated activity, reinforcing the notion of each subunit being functionally independent. This was further demonstrated using a monomeric form of IDH from Azotobacter vinelandii, which can be shown to gain the same neomorphic reaction when a homologous mutation is introduced into that protein.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700